These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15577628)

  • 21. Cost-Effectiveness of Pre-Exposure Prophylaxis Among Adolescent Sexual Minority Males.
    Wang LY; Hamilton DT; Rosenberg ES; Aslam MV; Sullivan PS; Katz DA; Dunville RL; Barrios LC; Goodreau SM
    J Adolesc Health; 2020 Jan; 66(1):100-106. PubMed ID: 31757626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.
    Landovitz RJ; Fletcher JB; Inzhakova G; Lake JE; Shoptaw S; Reback CJ
    AIDS Patient Care STDS; 2012 Jun; 26(6):320-8. PubMed ID: 22680280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
    Lurie P; Miller S; Hecht F; Chesney M; Lo B
    JAMA; 1998 Nov; 280(20):1769-73. PubMed ID: 9842953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
    Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
    Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
    BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US.
    Hellinger FJ
    Pharmacoeconomics; 2013 Dec; 31(12):1091-104. PubMed ID: 24271858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing HIV in injection drug users: choosing the best mix of interventions for the population.
    Wilson AR; Kahn JG
    J Urban Health; 2003 Sep; 80(3):465-81. PubMed ID: 12930884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.
    Talbird SE; Brogan AJ; Winiarski AP
    Am J Prev Med; 2009 Nov; 37(5):381-8. PubMed ID: 19840692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nurse-Led HIV PEP Program Used by Men at High Risk for HIV Seroconversion.
    O'Byrne P; MacPherson P; Orser L
    J Assoc Nurses AIDS Care; 2018; 29(4):550-559. PubMed ID: 29530543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is offering post-exposure prevention for sexual exposures to HIV related to sexual risk behavior in gay men?
    Waldo CR; Stall RD; Coates TJ
    AIDS; 2000 May; 14(8):1035-9. PubMed ID: 10853986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
    Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs.
    Li J; Gilmour S; Zhang H; Koyanagi A; Shibuya K
    AIDS; 2012 Oct; 26(16):2069-78. PubMed ID: 22781221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postexposure prophylaxis for HIV following sexual exposure.
    Barber TJ; Benn PD
    Curr Opin HIV AIDS; 2010 Jul; 5(4):322-6. PubMed ID: 20543608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of HIV-prevention skills training for men who have sex with men.
    Pinkerton SD; Holtgrave DR; Valdiserri RO
    AIDS; 1997 Mar; 11(3):347-57. PubMed ID: 9147427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High HIV incidence in men who have sex with men attending for postexposure prophylaxis: a service evaluation.
    Whitlock G; McCormack C; Fearnley J; McOwan A
    Sex Transm Infect; 2017 May; 93(3):214-216. PubMed ID: 27412954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
    Uyei J; Fiellin DA; Buchelli M; Rodriguez-Santana R; Braithwaite RS
    Lancet Public Health; 2017 Mar; 2(3):e133-e140. PubMed ID: 29253386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.